obesity. obesity,unspecified
Conditions
Interventions
Intervention 1: Intervention group spirulina platensis algae supplement 500 mg, 2 tablets a day, during 12 weeks of intervention. Intervention 2: Control group, placebo: 500 mg tablet containing starc
Treatment - Other
Treatment - Drugs
Intervention group spirulina platensis algae supplement 500 mg, 2 tablets a day, during 12 weeks of intervention
Control group, placebo: 500 mg tablet containing starch with the same appearance of the Spiruina supplement, 2 times daily for12 weeks
Sponsors
Vice chancellor for research, Tabriz University of Medical sciences
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: tendency to attend; obese individuals with BMI = 30 kg/m2; age group of 20 to 50. Exclusion criteria: history of renal disease; history of CVD; cancers; acute infections; recent surgeries; usage of weight effective drugs (hormone drugs); antidepressant drugs; diuretic drugs; antibiotics; glucocorticoids; usage of any supplements in the past 3 months; pregnancy; breast feeding; menopause; following weight loss diets in 3 months before and during the intervention.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum vascular endothelial growth factor. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: ELISA.;Serum lipid profile. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: spectrophotometry,immunoturbidimetry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Energy intake, Macronutrients. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: 24 hours recall questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mahdieh Abbasalizad Farhangi
Nutrition faculty, Tabriz University of Medical Sciences
Outcome results
None listed